
Jody Lynn Karol
Examiner (ID: 9001, Phone: (571)270-3283 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617 |
| Total Applications | 669 |
| Issued Applications | 257 |
| Pending Applications | 15 |
| Abandoned Applications | 398 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9739250
[patent_doc_number] => 20140274969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'USE OF MINOCYCLINE FOR THERAPEUTIC TREATMENT OF ACUTE SPINAL CORD INJURIES'
[patent_app_type] => utility
[patent_app_number] => 13/836380
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11863
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836380
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/836380 | USE OF MINOCYCLINE FOR THERAPEUTIC TREATMENT OF ACUTE SPINAL CORD INJURIES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9739389
[patent_doc_number] => 20140275108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS'
[patent_app_type] => utility
[patent_app_number] => 13/841524
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26374
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841524
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/841524 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9269706
[patent_doc_number] => 20140024624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'Method of Ameliorating Clotting Pathologies and Related Materials and Methods'
[patent_app_type] => utility
[patent_app_number] => 13/837021
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 7815
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837021 | Method of Ameliorating Clotting Pathologies and Related Materials and Methods | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9069334
[patent_doc_number] => 20130261090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'METHOD FOR TREATMENT OF SORES IN THE ORAL CAVITY WITH A COMPOSITION CONTAINING ULTRAVIOLET LIGHT-ABSORBING INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/832551
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3973
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13832551
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/832551 | METHOD FOR TREATMENT OF SORES IN THE ORAL CAVITY WITH A COMPOSITION CONTAINING ULTRAVIOLET LIGHT-ABSORBING INGREDIENTS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9569868
[patent_doc_number] => 20140187582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'SOLID DISPERSIONS OF AMORPHOUS PAROXETINE MESYLATE'
[patent_app_type] => utility
[patent_app_number] => 13/833963
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8700
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/833963 | Solid dispersions of amorphous paroxetine mesylate | Mar 14, 2013 | Issued |
Array
(
[id] => 9363805
[patent_doc_number] => 20140073678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'ANTI-PAIN AND ANTI-NAUSEA AND/OR VOMITING COMBINATORIAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/843718
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18539
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843718
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843718 | ANTI-PAIN AND ANTI-NAUSEA AND/OR VOMITING COMBINATORIAL COMPOSITIONS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 8964207
[patent_doc_number] => 20130203809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDRO-QUINOLINE FOR TREATING SKIN DISEASES AND CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/830311
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7549
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830311
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/830311 | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | Mar 13, 2013 | Issued |
Array
(
[id] => 11242584
[patent_doc_number] => 09468611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'd-Methadone for the treatment of psychiatric symptoms'
[patent_app_type] => utility
[patent_app_number] => 13/803375
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7307
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803375 | d-Methadone for the treatment of psychiatric symptoms | Mar 13, 2013 | Issued |
Array
(
[id] => 9223639
[patent_doc_number] => 20140018414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'METHODS OF INDUCING ANESTHESIA'
[patent_app_type] => utility
[patent_app_number] => 13/830907
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 41200
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/830907 | METHODS OF INDUCING ANESTHESIA | Mar 13, 2013 | Abandoned |
Array
(
[id] => 10279926
[patent_doc_number] => 20150164922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'USE OF TETRACYCLINE COMPOSITIONS FOR WOUND TREATMENT AND SKIN RESTORATION'
[patent_app_type] => utility
[patent_app_number] => 14/384978
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19109
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384978
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384978 | USE OF TETRACYCLINE COMPOSITIONS FOR WOUND TREATMENT AND SKIN RESTORATION | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9455342
[patent_doc_number] => 08716350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Compositions and methods for the treatment of somatosensory disorders'
[patent_app_type] => utility
[patent_app_number] => 13/829327
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 12034
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829327
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/829327 | Compositions and methods for the treatment of somatosensory disorders | Mar 13, 2013 | Issued |
Array
(
[id] => 10174909
[patent_doc_number] => 09205096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism'
[patent_app_type] => utility
[patent_app_number] => 13/828090
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10709
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13828090
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/828090 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism | Mar 13, 2013 | Issued |
Array
(
[id] => 9739539
[patent_doc_number] => 20140275257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'N-ACETYL CYSTEINE COMPOSITIONS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS'
[patent_app_type] => utility
[patent_app_number] => 13/826183
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 58592
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826183
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826183 | N-ACETYL CYSTEINE COMPOSITIONS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9739465
[patent_doc_number] => 20140275184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Cosmetic Compositions and Methods Providing Enhanced Penetration of Skin Care Actives'
[patent_app_type] => utility
[patent_app_number] => 13/803692
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12905
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803692
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803692 | Cosmetic compositions and methods providing enhanced penetration of skin care actives | Mar 13, 2013 | Issued |
Array
(
[id] => 9597797
[patent_doc_number] => 20140194478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'COMPOSITIONS FOR TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/801948
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3151
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801948
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801948 | COMPOSITIONS FOR TREATMENT OF CANCER | Mar 12, 2013 | Abandoned |
Array
(
[id] => 10049653
[patent_doc_number] => 09089506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Stable, non-irritating topical formulations of hydroquinone'
[patent_app_type] => utility
[patent_app_number] => 13/778696
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 17796
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13778696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/778696 | Stable, non-irritating topical formulations of hydroquinone | Feb 26, 2013 | Issued |
Array
(
[id] => 9793436
[patent_doc_number] => 20150005380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Gelling Formulation Based On Calcium Gluconate'
[patent_app_type] => utility
[patent_app_number] => 14/381316
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2369
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381316
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381316 | Gelling formulation based on calcium gluconate | Feb 26, 2013 | Issued |
Array
(
[id] => 8884806
[patent_doc_number] => 20130157990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'METHOD OF DRUG DETOXIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/771602
[patent_app_country] => US
[patent_app_date] => 2013-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12579
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13771602
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/771602 | METHOD OF DRUG DETOXIFICATION | Feb 19, 2013 | Abandoned |
Array
(
[id] => 9269723
[patent_doc_number] => 20140024641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'TREATMENT OF ORGANOPHOSPHATE EXPOSURE WITH TRIPTANS'
[patent_app_type] => utility
[patent_app_number] => 13/735456
[patent_app_country] => US
[patent_app_date] => 2013-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3962
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13735456
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/735456 | Treatment of organophosphate exposure with triptans | Jan 6, 2013 | Issued |
Array
(
[id] => 10920565
[patent_doc_number] => 20140323586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Agent for Reduction of Sensory Irritation'
[patent_app_type] => utility
[patent_app_number] => 14/361038
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8953
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361038
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361038 | Agent for reduction of sensory irritation | Jan 3, 2013 | Issued |